MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617066657 A) filed by Chiesi Farmaceutici S. P. A. on May 27, 2026, for Heteroaryl Amide Derivatives As Sodium Channel Inhibitors.
Inventors include Fiorelli, Claudio; Fossati, Giacomo; Mengozzi, Luca; Mosca, Giampaolo; Patacchini, Riccardo; and Rizzi, Andrea.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present invention generally relates to compounds of formula (I) inhibiting sodium channel (NaV) activity; particularly, the invention relates to compounds that are heteroaryl amide derivatives, including zwitterionic forms and pharmaceutically acceptable salts thereof, methods of preparing such compounds, and therapeutic use thereof. The compounds of the invention may be useful for instance in the treatment of many disorders associated with NaV, such as respiratory diseases.
Disclaimer: Curated by HT Syndication.
